Creating important molecules for treating diseases
Synthesis and Study of Medicinally Important Molecules
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11098187
This study is exploring new ways to create helpful medicines that could treat serious health issues like cancer and brain disorders, with the hope that these new treatments will work better against tough diseases.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11098187 on ClinicalTrials.gov |
What this research studies
This research focuses on developing new methods to synthesize both natural and synthetic molecules that could be used to treat serious health conditions like cancer and neurological disorders. By innovating organic synthesis techniques, the team aims to create compounds that can overcome challenges such as drug resistance in infectious diseases. The project involves profiling these molecules to understand how they work and optimizing them for use as potential new therapies. Patients may benefit from the eventual development of novel treatments derived from these synthesized molecules.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from cancer, neurological disorders, or infections that are resistant to current treatments.
Not a fit: Patients with conditions that are not related to cancer, neurological disorders, or infectious diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for cancer, neurological disorders, and drug-resistant infections.
How similar studies have performed: Other research has shown success in developing new therapies through innovative synthesis methods, indicating a promising approach.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DAI, MINGJI — EMORY UNIVERSITY
- Study coordinator: DAI, MINGJI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Treatment, Communicable Diseases